My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
COMPLIANCE INFO_1983-2005
Environmental Health - Public
>
EHD Program Facility Records by Street Name
>
H
>
HOSPITAL
>
500
>
4500 - Medical Waste Program
>
PR0450005
>
COMPLIANCE INFO_1983-2005
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
1/20/2023 2:39:39 PM
Creation date
7/3/2020 10:17:44 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
4500 - Medical Waste Program
File Section
COMPLIANCE INFO
FileName_PostFix
1983-2005
RECORD_ID
PR0450005
PE
4522
FACILITY_ID
FA0000086
FACILITY_NAME
San Joaquin General Hospital
STREET_NUMBER
500
Direction
W
STREET_NAME
HOSPITAL
STREET_TYPE
Rd
City
French Camp
Zip
95231
CURRENT_STATUS
01
SITE_LOCATION
500 W Hospital Rd
P_LOCATION
99
P_DISTRICT
001
QC Status
Approved
Scanner
SJGOV\cfield
Supplemental fields
FilePath
\MIGRATIONS\MW\MW_4522_PR0450005_500 W HOSPITAL_1983-2005.tif
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
260
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
State of California44ealth and Welfare Agency <br />:1 <br />Department of Health Services <br />SLVpbTeritary Sheet Amendment Nmter51 <br />22. The licensee shall elute generators and process radioactive material with reagent kits in accordance with <br />instructions furnished by the manufacturer on the label attached to or in the leaflet or brochure that <br />accompanies the generator or reagent kit. <br />23. Technetium 99m labelled pharmaceuticals prepared by the licensee by aseptic addition of pertechnetate to <br />sterile, pyrogen free reagents may be administered to humans provided the radioassay of the final product is <br />determined with an overall error not exceeding ten percent. When the pharmaceutical is prepared from reagents <br />procured in the form of approved kits, the licensee must strictly follow all instructions and recommendations <br />contained in the package insert information; otherwise the pharmaceutical must be prepared and compounded <br />from a prescription in accordance with the regulations of the California Board of Pharmacy. <br />24. The licensee is authorized to hold radioactive materials with a physical half life of less than 65 days for decay <br />in storage before disposal in ordinary trash provided: <br />(a) Radioactive waste to be disposed of in this manner shall be held for decay in storage for no less than 10 <br />half lives. <br />(b) Before disposal as normal waste, radioactive waste shall be surveyed to determine that its radioactivity <br />cannot be distinguished from background All radiation labels shall be removed or obliterated <br />25. Equipment for radiometric assay of pharmaceuticals, body fluids, excreta, or in -vitro assay samples shall be <br />calibrated to ensure reliability of data obtained. The stability of the equipment shall be checked at least once <br />each day of use, using appropriate standards. <br />26. Nuclear medicine technology procedures shall be performedby nuclear medicine technologists pursuant to the <br />California Code of Regulations, Title 17, Subchapter 4.6. Such procedures shall be performed under the <br />supervision of individuals listed as authorized users on this license who meet the criteria specified in Section <br />30510. Certificates or special permits issued pursuant to Subchapter 4.6 shall be prominently displayed at the <br />facility(ies) authorized on this license. <br />27. Treatment and management of patients receiving therapeutic quantities of unsealed radioactive materials shall <br />be in accordance with guidance contained in Chapta 4, "Release from Hospital of Patients Containing <br />Radioactive Material" National Council on Radiation Protection and Measurements (NCRP) Report No. 37, <br />"Precautions in the Management of Patients Who ve Received Therapeutic Amounts of Radionuclides" <br />(NCRP Publications, P. O. Box 30175, Washington, D. C., 20014). <br />28. This license does not authorize distribution to persons licensed pursuant to Section 30195 (a) and (b) of the <br />California Radiation Control Regulations or equivalent provisions of the NRC or Agreement States. <br />29. This license does not authorize commercial distribution of radioactive material. <br />30. Production or processing of radiopharmaceuticals for the purpose of distribution to other licensees is not <br />authorized by this license. <br />31. Radioactive materials shall be used by occupational workers in such a mariner that the dose limits specified <br />in Title 10, Code of Federal Regulations, Part 20, Subpart C (Sections 20.1201 through 20.1208) are not <br />exceeded <br />
The URL can be used to link to this page
Your browser does not support the video tag.